Drug Information

Drug General Information
Drug ID
D01UGG
Former ID
DIB004547
Drug Name
Sabarubicin
Synonyms
BMS-195615; MEN-10755
Drug Type
Small molecular drug
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 2 [521498]
Company
The Menarini Group
Formula
C32H37NO13
Canonical SMILES
c12c(C(=O)c3c(C1=O)cccc3)c(c1c(c2O)C[C@](C[C@@H]1O[C@@H<br />]1O[C@H]([C@H]([C@H](C1)O)O[C@@H]1O[C@H]([C@H]([C@H](C1<br />)N)O)C)C)(C(=O)CO)O)O
PubChem Compound ID
46233105
Target and Pathway
Target(s) DNA topoisomerase II Target Info Modulator [1572591]
References
Ref 521498ClinicalTrials.gov (NCT00027781) MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy. U.S. National Institutes of Health.
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.